000154584 001__ 154584
000154584 005__ 20210129213925.0
000154584 0247_ $$2doi$$a10.1051/radiopro:2008664
000154584 0247_ $$2ISSN$$a0033-8451
000154584 0247_ $$2ISSN$$a1769-700X
000154584 037__ $$aFZJ-2014-03878
000154584 041__ $$aEnglish
000154584 082__ $$a530
000154584 1001_ $$0P:(DE-HGF)0$$aBrzozowska, K.$$b0$$eCorresponding Author
000154584 1112_ $$a36th Annual Meeting of the European Radiation Research Society$$cTours$$gERRS$$wFrance
000154584 245__ $$aComparison of Individual Radiosensitivity of PBL from Prostate Cancer Patients and Healthy Donors
000154584 260__ $$aLes Ulis$$bEDP Sciences$$c2008
000154584 3367_ $$2DRIVER$$aarticle
000154584 3367_ $$2DataCite$$aOutput Types/Journal article
000154584 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1507190264_26350
000154584 3367_ $$2BibTeX$$aARTICLE
000154584 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000154584 3367_ $$00$$2EndNote$$aJournal Article
000154584 520__ $$aIndividual radiosensitivity is a biological feature distributed heterogeneously withinthe population. Approximately 10 % of people have an enhanced intrinsic radiosensitvityand hence a higher risk for developing side effects during radiotherapy. Theunderlying mechanisms remain unclear. DNA repair deficiency and altered apoptosischaracteristics are discussed to be markers for radiosensitivity that can easilybe analysed in peripheral blood lymphocytes (PBL). The aim of our study is tofind out whether PBL from cancer patients with strong clinical side effects underradiotherapy, as assessed clinically on the basis of the RTOG/EORTC scale,show enhanced rates of double strand breaks (dsb), decreased DNA repair capacityand altered induction of apoptosis in vitro when compared to lymphocytes frompatients without side effects and age-matched healthy donors. Additionally, toinvestigate whether the in vitro radiosensitivity of PBL is a marker of prostatecancer predisposition the data of patients are analysed versus the data of PBLcollected from healthy donors. To achieve this goal blood samples are collected,exposed to a dose of 1 Gy or 0.5 Gy and the following biological endpoints are analysed:the initial level of dsb and the repair kinetics (°-H2AX-Assay), apoptosis(Annexin V-Assay) and the induction of chromatid-type chromosomal aberrations(G2-Assay). Preliminary results reveal that the maximum induction of foci asmeasured by °-H2AX-Assay occurs 30 min after irradiation. 24 h after irradiationthe amount of foci declines to approximately control level. FACS data confirmthese findings. First results derived from the Annexin V-Assay show a significantincrease of early apoptosis 24 h after irradiation compared to the controls.
000154584 536__ $$0G:(DE-HGF)POF2-899$$a899 - ohne Topic (POF2-899)$$cPOF2-899$$fPOF I$$x0
000154584 588__ $$aDataset connected to CrossRef, juser.fz-juelich.de
000154584 65027 $$0V:(DE-MLZ)SciArea-160$$2V:(DE-HGF)$$aBiology$$x0
000154584 7001_ $$0P:(DE-HGF)0$$aWojcik, A.$$b1
000154584 7001_ $$0P:(DE-Juel1)133469$$aKriehuber, R.$$b2
000154584 7001_ $$0P:(DE-Juel1)133346$$aSchmitz, Sabine$$b3$$ufzj
000154584 773__ $$0PERI:(DE-600)2236568-0$$a10.1051/radiopro:2008664$$gVol. 43, no. 5, p. 198$$n5$$pp.241$$tRadioprotection$$v43$$x1769-700X$$y2008
000154584 8564_ $$uhttps://juser.fz-juelich.de/record/154584/files/Brzozowska%20et%20al%20-%202008%20Tours%20-%20France-%20Conference%20paper%20due%20to%20Poster.pdf$$yRestricted
000154584 8564_ $$uhttps://juser.fz-juelich.de/record/154584/files/Brzozowska%20et%20al%20-%202008%20Tours%20-%20France-%20Conference%20paper%20due%20to%20Poster.gif?subformat=icon$$xicon$$yRestricted
000154584 8564_ $$uhttps://juser.fz-juelich.de/record/154584/files/Brzozowska%20et%20al%20-%202008%20Tours%20-%20France-%20Conference%20paper%20due%20to%20Poster.jpg?subformat=icon-1440$$xicon-1440$$yRestricted
000154584 8564_ $$uhttps://juser.fz-juelich.de/record/154584/files/Brzozowska%20et%20al%20-%202008%20Tours%20-%20France-%20Conference%20paper%20due%20to%20Poster.jpg?subformat=icon-180$$xicon-180$$yRestricted
000154584 8564_ $$uhttps://juser.fz-juelich.de/record/154584/files/Brzozowska%20et%20al%20-%202008%20Tours%20-%20France-%20Conference%20paper%20due%20to%20Poster.jpg?subformat=icon-640$$xicon-640$$yRestricted
000154584 8564_ $$uhttps://juser.fz-juelich.de/record/154584/files/Brzozowska%20et%20al%20-%202008%20Tours%20-%20France-%20Conference%20paper%20due%20to%20Poster.pdf?subformat=pdfa$$xpdfa$$yRestricted
000154584 909CO $$ooai:juser.fz-juelich.de:154584$$pVDB
000154584 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)133469$$aForschungszentrum Jülich GmbH$$b2$$kFZJ
000154584 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)133346$$aForschungszentrum Jülich$$b3$$kFZJ
000154584 9132_ $$0G:(DE-HGF)POF3-899$$1G:(DE-HGF)POF3-890$$2G:(DE-HGF)POF3-800$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000154584 9131_ $$0G:(DE-HGF)POF2-899$$1G:(DE-HGF)POF2-890$$2G:(DE-HGF)POF2-800$$3G:(DE-HGF)POF2$$4G:(DE-HGF)POF$$aDE-HGF$$bProgrammungebundene Forschung$$lohne Programm$$vohne Topic$$x0
000154584 915__ $$0StatID:(DE-HGF)0040$$2StatID$$aPeer review unknown
000154584 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR
000154584 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000154584 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000154584 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000154584 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS
000154584 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000154584 920__ $$lyes
000154584 9201_ $$0I:(DE-Juel1)S-US-20090406$$kS-US$$lSicherheit und Strahlenschutz, Umgebungsüberwachung,Strahlenbiologie$$x0
000154584 980__ $$ajournal
000154584 980__ $$aVDB
000154584 980__ $$aI:(DE-Juel1)S-US-20090406
000154584 980__ $$aUNRESTRICTED